FDA Head Says A COVID-19 Vaccine Could Get Emergency Approval Without Phase 3 Trial Results: FTBenzinga • 08/31/20
Johnson & Johnson: Accelerating Their Virus Vaccine Development And The Buy Of Momenta With Debt Is A Good MoveSeeking Alpha • 08/25/20
Johnson & Johnson to acquire Momenta Pharmaceuticals for $6.5 billionThe Dog of Wall Street • 08/22/20
U.S. FDA Approves New DARZALEX® (daratumumab)-Based Combination Regimen for Patients with Relapsed/Refractory Multiple MyelomaPRNewsWire • 08/20/20
Johnson & Johnson to Launch Late-Stage Coronavirus Vaccine Trials in SeptemberThe Motley Fool • 08/20/20
Johnson & Johnson to start late-stage coronavirus vaccine trial in September with up to 60,000 peopleCNBC • 08/20/20
MOMENTA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Momenta Pharmaceuticals, Inc. - MNTABusiness Wire • 08/20/20